far
away
import
pulmonari
diseas
man
relat
smoke
tobacco
howev
occup
lung
diseas
caus
inhal
industri
chemic
particul
matter
antigen
also
import
caus
morbid
mortal
reason
consider
effort
direct
examin
airborn
pollut
recent
year
includ
studi
effect
laboratori
anim
administ
inhal
rout
extens
studi
shown
complex
array
defens
mechan
protect
lung
advers
effect
airborn
substanc
pathogen
organ
aerodynam
factor
prevent
access
particl
larger
diamet
deposit
wall
nasal
passag
particl
measur
diamet
tend
trap
mucuscov
ciliat
epithelium
line
bronchial
tree
remov
mucociliari
transport
aid
cough
reflex
smaller
particl
may
reach
alveoli
ingest
transport
pulmonari
macrophag
murphi
florman
contrast
advers
pulmonari
effect
cigarett
smoke
industri
pollut
therapeut
agent
remain
rel
minor
caus
pulmonari
toxic
man
although
actual
incid
difficult
ascertain
howev
druginduc
pulmonari
diseas
appear
increasingli
frequent
clinic
problem
drug
associ
parenchym
pulmonari
injuri
human
continu
increas
holling
druginduc
toxic
usual
occur
exposur
lung
tissu
via
circul
either
parent
drug
metabolit
way
drug
affect
respiratori
system
man
summaris
grant
holling
review
specif
drug
implic
specif
pharmacolog
action
drug
produc
excess
effect
bronchial
calibr
pulmonari
function
drug
mediat
allerg
reaction
bronchi
lung
may
also
produc
varieti
obscur
diffus
pulmonari
alveolar
condit
includ
pulmonari
syndrom
resembl
system
lupu
erythematosu
respiratori
tract
major
rout
microorgan
gain
entri
bodi
opportunist
pulmonari
infect
bacteria
virus
fungi
protozoa
consequ
immunosuppress
broadspectrum
antibacteri
therapi
organ
drug
disturb
coagul
may
precipit
pulmonari
thromboembol
haemorrhag
localis
lung
lesion
also
result
accident
diagnost
therapeut
inhal
xenobiot
mucociliari
clearanc
also
sensit
therapeut
agent
affect
secret
mucu
fluid
ciliari
activ
transport
sturgess
treatment
antacid
histamin
h
blocker
also
increas
risk
pneumonia
develop
patient
intens
care
unit
increas
gastric
ph
lead
overgrowth
gramneg
bacteria
stomach
retrograd
pharyng
colonis
craven
et
al
preclin
safeti
studi
patholog
respiratori
system
result
intercurr
diseas
induc
drug
administ
system
recent
year
increas
interest
deliveri
therapeut
agent
inhal
intranas
rout
ranney
intranas
inhal
mode
therapi
pose
particular
challeng
term
novel
formul
technolog
requir
administ
drug
well
potenti
impact
differ
anatom
physiolog
characterist
airway
drug
toxic
disposit
metabol
develop
drug
administ
inhal
intranas
rout
particularli
difficult
perceiv
risk
high
local
drug
concentr
respiratori
tissu
alter
drug
disposit
potenti
vulner
patient
popul
often
pulmonari
diseas
degeorg
et
al
complex
scienc
technolog
develop
support
assess
advers
effect
inhal
substanc
rodent
nonrod
speci
extrapol
experiment
find
man
dorato
dorato
wolff
order
administ
xenobiot
includ
drug
inhal
necessari
gener
aerosol
suspens
particl
ga
welldefin
composit
particl
size
shape
must
deliv
respiratori
tract
laboratori
anim
way
parallel
like
human
exposur
case
therapeut
agent
avoid
nonrespiratori
pathway
skin
food
aerosol
inhal
variou
fraction
particl
deposit
differ
locat
respiratori
tract
site
deposit
depend
primarili
particl
size
variabl
site
deposit
occur
among
differ
laboratori
anim
speci
man
virtu
differ
size
shape
respiratori
passag
well
breath
pattern
sweeney
brain
rel
distribut
monodispers
aerosol
man
rat
found
compar
particl
diamet
inhal
differ
size
rang
raab
subsequ
fate
inhal
particl
depend
size
also
shape
chemic
natur
solubl
bodi
fluid
solubl
substanc
absorb
blood
stream
remov
pulmonari
circul
may
also
undergo
metabol
enzym
present
cell
popul
respiratori
tract
reactiv
metabolit
may
caus
local
pulmonari
damag
insolubl
inert
particl
remov
primarili
mucociliari
transport
system
trachea
bronchi
phagocytosi
macrophag
overload
lung
even
rel
inert
nonfibr
particl
titanium
dioxid
carbon
black
may
impair
alveolar
macrophagemedi
particl
clearanc
warheit
et
al
may
lead
turn
accumul
dust
time
eventu
fibrot
tumorigen
respons
key
compon
evalu
effect
inhal
substanc
care
morpholog
assess
fix
tissu
measur
respir
rate
tidal
volum
airway
resist
pulmonari
ga
exchang
disposit
inhal
substanc
also
critic
place
evalu
chemic
induc
lung
damag
laboratori
anim
nemeri
et
al
sever
variabl
respiratori
pattern
rodent
measur
simultan
whole
bodi
plethysmographi
use
modest
restraint
coggin
et
al
costa
nasal
chamber
structur
first
subject
effect
inhal
substanc
whether
microorgan
chemic
substanc
although
chamber
usual
examin
great
detail
convent
toxic
studi
substanc
administ
oral
parenter
rout
care
examin
histolog
drug
administ
inhal
studi
nasopharyng
silicon
rubber
cast
shown
consider
speci
differ
anatomi
part
airway
patra
harkema
harkema
resnik
rel
total
nasal
length
nasopharynx
longest
rat
shortest
man
dog
intermedi
posit
maxilloturbin
rel
simpl
structur
man
nonhuman
primat
highli
complex
dog
rodent
consequ
region
nasal
airflow
disposit
pattern
vari
consider
influenc
distribut
lesion
produc
inhal
xenobiot
nasal
caviti
morgan
monticello
anterior
nare
line
stratifi
squamou
epithelium
zone
sinus
cover
either
respiratori
olfactori
epithelium
zone
transit
epithelium
junction
two
type
respiratori
epithelium
similar
found
elsewher
respiratori
passag
compos
ciliat
cell
serou
mucou
cell
brush
cell
intermedi
cell
progenitor
basal
cell
repres
cellular
system
engag
mucociliari
clearanc
carri
surfac
secret
nasopharynx
clear
swallow
proctor
although
epithelium
similar
line
larg
airway
key
differ
particularli
rich
complement
secretori
cell
complex
vasculatur
nose
modul
capillari
arteri
venou
blood
flow
mucosa
proctor
mucin
may
particularli
import
postul
physic
protect
function
also
possess
antioxid
properti
virtu
scaveng
properti
high
proport
sugar
group
cross
et
al
proport
nose
line
olfactori
mucosa
variabl
speci
dispos
much
larger
area
dog
rodent
primat
harkema
howev
structur
similar
man
rodent
locat
dorsal
posterior
region
nasal
passag
direct
line
airflow
normal
respir
olfactori
mucosa
pseudostratifi
columnar
epithelium
compos
basal
cell
sustentacular
cell
sensori
cell
mucussecret
bowman
gland
situat
lamina
propria
basal
cell
compos
two
distinct
type
light
dark
cell
light
type
repres
primit
stem
cell
popul
sustentacular
support
cell
noncili
columnar
cell
possess
microvilli
extend
overli
layer
mucu
cell
bodi
olfactori
sensori
neuron
situat
middl
layer
epithelium
sustentacular
basal
cell
dendrit
process
extend
epitheli
surfac
end
ciliat
expans
refer
olfactori
vesicl
believ
receptor
odour
percept
olfactori
axon
extend
cell
bodi
penetr
basement
membran
bundl
becom
surround
schwann
cell
eventu
join
olfactori
bulb
olfactori
system
import
toxicolog
select
damag
xenobiot
includ
therapeut
agent
presum
result
high
metabolis
capac
superfici
locat
neural
cell
olfactori
epithelium
also
provid
model
system
studi
effect
xenobiot
neural
cell
submucos
mucou
gland
well
characteris
rat
hamster
divid
later
nasal
gland
maxillari
recess
gland
situat
posterior
part
nasal
caviti
compos
mucussecret
cell
vidic
greditz
adam
similar
gland
also
characteris
nasal
caviti
dog
adam
et
al
immunocytochem
studi
use
antisera
rais
major
isoenzym
rat
hepat
microsom
cytochrom
induc
phenobarbiton
well
nadphcytochrom
reductas
epoxid
hydrolas
glutathion
stransferas
b
c
e
shown
presenc
immunereact
enzym
rat
nasal
mucos
cell
baron
et
al
suggest
nasal
mucosa
capac
metabolis
activ
xenobiot
oxid
also
hydrat
inactiv
potenti
toxic
epoxid
conjug
electrophil
reactiv
metabolit
reduc
glutathion
addit
shown
distribut
immunereact
enzym
differ
olfactori
respiratori
mucosa
differ
correl
activ
shown
enzym
histochem
method
bogdanffi
xenobiot
metabolis
within
olfactori
respiratori
mucosa
olfactori
region
appear
possess
greatest
capabl
oxid
metabol
consequ
region
differ
nasal
toxic
tumour
format
inhal
materi
may
respons
differ
water
solubl
deposit
pattern
also
differ
format
reactiv
metabolit
bogdanffi
anoth
featur
metabolis
activ
induc
system
administ
xenobiot
occur
way
alter
distribut
enzym
activ
nasal
mucosa
baron
et
al
rodent
rel
small
size
nose
nasal
sinus
facilit
histolog
examin
usual
area
section
transvers
sever
standardis
block
follow
decalcif
young
number
detail
public
describ
histolog
prepar
assess
patholog
rodent
nasal
caviti
tyler
et
al
uraih
maronpot
morgan
describ
approach
adopt
identif
record
lesion
toxic
studi
larger
speci
particularli
dog
primat
section
block
complex
although
dissect
requir
similar
procedur
follow
decalcif
adopt
levinski
et
al
examin
cytokeratin
express
respiratori
mucosa
also
use
marker
epitheli
differenti
respiratori
tract
schlage
et
al
publish
detail
account
cytokeratin
pattern
rat
nasal
mucosa
purpos
like
mani
tissu
expos
extern
environment
agent
nasal
mucosa
possess
aggreg
lymphoid
tissu
underli
lamina
propria
rat
area
characteris
follicl
contain
tand
bcell
area
locat
ventral
aspect
later
wall
nasal
airway
open
nasopharyng
duct
spit
et
al
harkema
like
gutassoci
lymphoid
tissu
nasal
follicl
shown
rat
cover
specialis
epithelium
island
cell
microvilli
call
membran
cell
spit
et
al
test
system
relat
innerv
nasal
mucosa
propos
alari
enabl
detect
airborn
sensori
irrit
predict
accept
level
exposur
upper
respiratori
tract
man
trigemin
nerv
end
nasal
mucosa
mice
mediat
respons
sensori
irrit
measur
decreas
respiratori
rate
shown
good
correl
exist
decreas
respir
rate
mice
expos
airborn
chemic
nasal
irrit
potenti
chemic
man
alari
infecti
agent
caus
inflamm
nose
nasal
sinus
may
associ
inflamm
conjunctiva
middl
ear
oral
caviti
murin
pathogen
may
caus
alter
respiratori
tract
confound
assess
chang
induc
xenobiot
everitt
richter
rat
microbiolog
agent
implic
develop
rhiniti
sinus
includ
corynebacterium
kutscheri
pseudotuberculosi
streptococcu
pneumonia
pasteurella
pneumotropica
klebsiella
pneumonia
mycoplasma
pulmoni
sialodacryoaden
viru
rat
corona
viru
greav
faccini
rat
infect
sialodacryoaden
viru
show
inflamm
necrosi
upper
respiratori
epithelium
well
salivari
lachrym
gland
sendai
viru
paramyxoviru
also
mark
tropism
respiratori
tract
includ
nasal
caviti
associ
system
effect
compromis
studi
laboratori
rodent
occasion
fungal
infect
airway
aspergillu
fumigatu
report
everitt
richter
variabl
shown
influenc
sever
rhiniti
produc
mycoplasma
pulmoni
strain
rat
follow
hous
lew
strain
togeth
elimin
microbi
environment
differ
davi
cassel
show
lew
strain
develop
sever
rhiniti
follow
inocul
mycoplasma
pulmoni
rat
although
reason
differ
unclear
rat
expos
ammonia
common
pollut
air
laboratori
anim
cage
also
shown
develop
lesion
dorsal
meatu
dorsal
nasal
septum
promin
turbin
lesion
characteris
histolog
swell
mild
degener
epithelium
pinson
et
al
appear
ammonia
exposur
potenti
acut
inflammatori
respons
nasal
caviti
microbiolog
pathogen
pinson
et
al
microorgan
report
nasal
caviti
rhesu
monkey
employ
inhal
studi
nematod
genu
anatrichosoma
klonn
et
al
section
nematod
found
squamou
epithelium
nasal
vestibul
associ
acanthosi
hyperkeratosi
epithelium
multifoc
diffus
granulomat
inflamm
submucosa
administr
toxic
irrit
substanc
laboratori
anim
inhal
rout
produc
degen
inflammatori
reactiv
chang
nasal
mucosa
rang
histolog
featur
similar
found
mucos
surfac
damag
exogen
agent
exampl
type
distribut
degen
inflammatori
condit
induc
inhal
irrit
provid
studi
swisswebst
mice
given
variou
irrit
inhal
period
hoursday
day
concentr
produc
decreas
respiratori
rate
alari
test
although
degre
histolog
chang
vari
differ
agent
chang
broadli
similar
type
distribut
buckley
et
al
agent
examin
produc
littl
alter
squamou
mucosa
line
anterior
part
nose
apart
mild
increas
thick
squamou
epithelium
principl
site
damag
shown
anterior
respiratori
epithelium
adjac
vestibul
olfactori
epithelium
dorsal
meatu
distinct
decreas
sever
posterior
region
histolog
lesion
respiratori
epithelium
rang
mild
loss
cilia
small
area
epitheli
exfoli
frank
eros
ulcer
necrosi
epithelium
underli
tissu
includ
bone
variabl
polymorphonuclear
cell
infiltr
also
found
case
earli
squamou
metaplasia
develop
free
margin
nasomaxilloturbin
chang
olfactori
epithelium
vari
focal
extens
loss
sensori
cell
associ
damag
sustentacular
cell
sever
case
complet
loss
olfactori
epithelium
occur
although
degre
histolog
chang
shown
vari
differ
agent
lesion
induc
watersolubl
chemic
tend
remain
localis
anterior
part
nasal
caviti
wherea
agent
rel
low
water
solubl
produc
lung
lesion
addit
suggest
find
demonstr
power
scrub
action
nasal
caviti
water
solubl
airborn
xenobiot
buckley
et
al
similar
inflammatori
alter
induc
nasal
caviti
rodent
treat
therapeut
agent
inhal
howev
precis
relev
chang
human
therapi
inhal
rout
sometim
question
nasal
damag
limit
high
dose
associ
alter
part
respiratori
tract
case
tulobuterol
adrenerg
receptor
agonist
argu
nasal
inflamm
induc
rat
month
inhal
toxic
studi
result
particularli
high
exposur
nasal
epithelium
drug
repres
like
human
exposur
tulobuterol
inhal
littl
nasal
exposur
would
occur
dudley
et
al
walsh
courtney
describ
nasal
epitheli
degener
necrosi
rat
dog
treat
candid
antiinflammatori
drug
intranas
rout
agent
effect
olfactori
epithelium
respiratori
mucosa
suggest
metabol
import
gener
toxic
two
instruct
exampl
drug
caus
toxic
rat
olfactori
mucosa
provid
novel
type
iv
phosphodiesteras
inhibitor
rp
methimazol
thioureylen
antithyroid
drug
use
clinic
practic
rp
n
develop
treatment
asthma
rheumatoid
arthriti
produc
degener
olfactori
epithelium
rat
neither
dog
mice
singl
repeat
oral
dose
inhal
pino
et
al
histolog
olfactori
epithelium
show
necrosi
superfici
epitheli
layer
includ
sustentacular
sensori
cell
spare
basal
cell
layer
also
damag
bowman
gland
develop
prolif
lesion
ultim
tumour
princip
neuroectoderm
origin
follow
chronic
treatment
rp
highli
metabolis
nasal
lesion
could
inhibit
treatment
rat
metyrapon
nonspecif
inhibitor
cytochrom
postul
chang
result
activ
olfactori
tissu
link
pharmacolog
phosphodiesteras
activ
pino
et
al
methimazol
contrast
rp
use
clinic
practic
oral
dose
mgkgday
employ
administr
methimazol
rel
high
dose
longevan
rat
singl
oral
mgkg
intraperiton
mgkg
rout
also
produc
complet
damag
sustentacular
sensori
cell
spare
basal
cell
basement
membran
genter
et
al
bowman
gland
also
involv
methimazol
metabolis
flavincontain
monooxygenas
system
particularli
also
employ
model
substrat
enzym
vitro
genter
et
al
demonstr
presenc
flavincontain
monooxygenas
isoform
olfactori
microsom
longevan
rat
postul
reactiv
intermedi
respons
nasal
toxic
risk
damag
human
olfactori
cell
agent
effect
rat
nasal
mucosa
often
remain
uncertain
understand
rel
exposur
metabol
differ
speci
better
understand
metabol
potenti
human
olfactori
mucosa
requir
particular
respons
rodent
nasal
mucosa
irrit
substanc
includ
pharmaceut
agent
format
round
eosinophil
inclus
cytoplasm
sustentacular
cell
olfactori
epithelium
lesser
extent
respiratori
glandular
epitheli
cell
buckley
et
al
gopinath
et
al
inclus
pasneg
ultrastructur
examin
show
membranebound
ellipsoid
bodi
contain
homogen
electron
dens
matrix
signific
remain
uncertain
standard
classif
varieti
prolif
nonneoplast
chang
found
rat
nasal
caviti
repres
larg
adapt
respons
injuri
defin
societi
toxicolog
pathologist
classif
schwartz
et
al
similarli
atyp
epitheli
lesion
neoplasm
also
includ
standardis
classif
classif
intern
agenc
research
cancer
provid
similar
perspect
mohr
lesion
may
occasion
seen
untreat
rodent
carcinogen
studi
much
commonli
induc
administr
xenobiot
inhal
carcinogen
studi
spontan
nasal
tumour
uncommon
often
squamou
type
rat
wherea
mice
spontan
squamou
tumour
extrem
rare
haemangioma
respiratori
adenoma
predomin
brown
et
al
haseman
et
al
gener
agre
categori
describ
chang
affect
nasal
respiratori
epithelium
characteris
presenc
enlarg
mucusfil
goblet
cell
form
cluster
suggest
intraepitheli
gland
seen
stratifi
squamou
epithelium
nare
characteris
focal
increas
number
cell
layer
cell
may
show
atypia
irregular
enlarg
pleomorph
nuclei
nucleoli
squamou
metaplasia
occur
respiratori
epithelium
condit
chronic
damag
characteris
histolog
presenc
three
layer
epitheli
cell
eosinophil
cytoplasm
clear
cell
boundari
wherea
advanc
lesion
show
typic
keratin
format
intercellular
bridg
cellular
atypia
may
also
seen
characteris
found
repres
atrophi
degener
olfactori
epithelium
loss
sensori
cell
advanc
case
loss
sustentacular
cell
replac
ciliat
noncili
respiratori
epithelium
may
seen
spontan
focal
lesion
age
rat
term
epitheli
hyperplasia
cellular
atypia
use
embrac
prolif
lesion
respiratori
olfactori
mucosa
nasal
caviti
vari
degre
alter
differenti
atypia
perturb
growth
pattern
epithelium
chang
found
normal
regen
respons
transient
mucos
damag
adenoma
usual
develop
anterior
part
nasal
caviti
usual
exophyt
lesion
develop
respiratori
epithelium
nasal
gland
adenoma
respiratori
epithelium
may
papillari
form
definit
well
circumscrib
minim
cellular
pleomorph
atypia
may
occasion
occur
spontan
age
rat
brown
et
al
adenoma
nasal
gland
usual
show
acinar
pattern
develop
squamou
epithelium
nare
area
squamou
metaplasia
respiratori
olfactori
epithelium
exophyt
lesion
limit
connect
tissu
stroma
may
develop
spontan
age
rat
hayashi
et
al
squamou
cell
carcinoma
adenocarcinoma
develop
nasal
mucosa
histolog
similar
characterist
epitheli
tissu
rare
spontan
lesion
age
laboratori
rodent
may
induc
xenobiot
administ
inhal
oral
parenter
rout
squamou
carcinoma
report
develop
small
number
untreat
fischer
rat
use
carcinogen
studi
associ
point
mutat
chra
ckra
gene
hayashi
et
al
neoplasm
show
olfactori
differenti
aris
olfactori
epithelium
seem
occur
spontan
lesion
rat
mice
brown
et
al
schwartz
et
al
cell
arrang
lobul
solid
sheet
scanti
stroma
cell
rel
uniform
scanti
cytoplasm
round
oval
hyperchromat
nuclei
true
rosett
lumen
pseudorosett
also
seen
poorli
differenti
tumour
type
may
requir
ultrastructur
studi
diagnosi
olfactori
neuroblastoma
typic
show
presenc
electrondens
neurosecretori
granul
neurofila
axon
detail
understand
biolog
behaviour
neoplasm
laboratori
rodent
gener
term
olfactori
neuroblastoma
usual
prefer
almost
alway
invas
tumour
brown
et
al
olfactori
carcinoma
form
gland
follicl
rosett
occasion
report
age
syrian
hamster
pour
et
al
pour
et
al
may
seen
nasal
caviti
particularli
exposur
potent
carcinogen
histolog
featur
similar
soft
tissu
bone
elsewher
bodi
see
chapter
mucosa
line
larynx
trachea
becom
involv
part
upper
lower
respiratori
tract
infect
instanc
rat
acut
laryng
tracheiti
shown
accompani
experiment
infect
mycoplasma
pulmoni
sialodycroaden
viru
davi
cassel
wojcinski
perci
spontan
degen
condit
tracheal
laryng
cartilag
associ
granuloma
report
fischer
rat
germann
et
al
caus
condit
unknown
increas
sever
incid
advanc
age
although
seen
rat
young
week
age
larynx
rodent
also
suscept
effect
inhal
substanc
notabl
tobacco
smoke
also
pharmaceut
agent
propel
coggin
et
al
gopinath
et
al
sagartz
et
al
view
localis
natur
induc
lesion
larynx
standardis
histolog
section
techniqu
propos
rat
mice
hamster
use
anatom
landmark
sagartz
et
al
renn
et
al
renn
et
al
target
site
locat
ventral
floor
larynx
near
base
epiglotti
cranial
ventral
laryng
diverticulum
lesion
tend
occur
ventrolater
region
cover
respiratori
epithelium
inner
aspect
arytenoid
process
line
squamou
mucosa
larynx
respond
inhal
irrit
inflammatori
degen
regen
chang
manner
similar
region
respiratori
tract
includ
disrupt
epitheli
cell
inflammatori
cell
exud
infiltr
goblet
cell
hyperplasia
squamou
metaplasia
coggin
et
al
howev
chang
specif
inhal
irrit
also
occur
respons
natur
respiratori
tract
pathogen
convent
hous
rat
lewi
pseudostratifi
ciliat
noncili
mucosa
trachea
may
also
show
patholog
alter
inhal
studi
although
site
bifurc
carina
often
first
affect
consequ
carina
systemat
includ
examin
respiratori
tract
induc
lesion
schwartz
et
al
nasal
passag
rang
prolif
lesion
includ
squamou
hyperplasia
mucou
cell
hyperplasia
well
papilloma
carcinoma
mesenchym
tumour
occasion
report
airway
laboratori
rodent
man
laboratori
anim
trachea
termin
bifurc
give
rise
two
main
bronchi
serv
left
right
lung
depend
speci
main
bronchi
subdivid
branch
enter
differ
lobe
variou
form
branch
recognis
bronchi
may
aris
sidebranch
parent
stem
bronchu
monopodi
parent
bronchu
divid
two
equal
daughter
bronchu
dichotom
sever
daughter
bronchi
polychotom
yeh
studi
silicon
rubber
cast
respiratori
tract
shown
bronchial
tree
man
nonhuman
primat
essenti
dichotom
contrast
monopodi
pattern
rodent
patra
compar
long
trachea
dog
give
rise
dichotom
upper
airway
monopodi
branch
develop
peripher
within
lobe
size
lung
depend
size
weight
differ
speci
although
dog
compar
smaller
bodi
mass
higher
airway
dimens
compar
man
patra
number
lobe
speciesdepend
human
lung
possess
upper
lower
left
lobe
upper
middl
lower
right
lobe
contrast
upper
middl
lower
left
lobe
fourth
azygo
right
lobe
rhesu
monkey
baboon
hartman
strau
patra
dog
three
lobe
right
left
side
rat
mice
hamster
show
cranial
middl
caudal
postcav
right
lobe
singl
left
lobe
mice
rat
superior
inferior
lobe
left
side
hamster
cell
type
line
bronchi
gener
similar
speci
although
subtyp
clearli
determin
everi
speci
review
sturgess
major
cell
ciliat
cell
accompani
variabl
rel
smaller
proport
basal
cell
intermedi
cell
mucou
goblet
cell
serou
cell
neuroendocrin
brush
cell
addit
mucou
cell
line
adjac
bronchial
gland
dorman
unlik
tracheal
mucosa
pseudostratifi
mucosa
intrapulmonari
bronchi
nonstratifi
ciliat
cell
tall
columnar
cell
attach
basal
intermedi
cell
desmosom
junction
tight
junction
exist
adjac
specialis
cell
apex
cell
possess
cilia
engag
mucociliari
clearanc
serafini
michaelson
superfici
cell
surfac
also
show
pronounc
glycocalyx
cytoplasm
ciliat
cell
contain
scatter
profil
rough
endoplasm
reticulum
supranuclear
golgi
numer
mitochondria
particularli
near
apex
promin
cytoskeleton
also
found
mucou
goblet
cell
typic
mucussecret
cell
repres
bronchial
mucosa
cell
popul
man
less
pathogenfre
rat
sturgess
serou
cell
cylindr
pyramid
cell
contain
small
round
close
pack
serou
granul
dorman
mucussecret
ciliat
cell
form
cellular
basi
mucociliari
clearanc
mechan
main
conduct
airway
epithelium
cover
mucou
blanket
fairli
complet
man
rabbit
patchier
rat
sturgess
mucou
layer
segreg
upper
layer
gel
phase
separ
epitheli
cell
serou
layer
sol
phase
complex
carbohydr
glycocalyx
secret
mucosubst
show
speciesrel
differ
sugar
residu
demonstr
histochem
use
labelledlectin
geleff
et
al
mucociliari
clearanc
mechan
sensit
effect
mani
therapeut
agent
particularli
influenc
mucin
fluid
electrolyt
balanc
ciliari
activ
anaesthet
gase
barbitur
narcot
alcohol
depress
clearanc
function
contrast
topic
oral
parenter
administr
agonist
isoprenalin
adrenalin
produc
dosedepend
stimul
mucociliari
transport
effect
ciliari
beat
frequenc
probabl
mediat
increas
level
cyclic
adenosin
monophosph
ciliat
cell
rather
vascular
chang
although
basal
mucociliari
function
depend
normal
vagal
tone
parasympathomimet
agent
affect
mucociliari
transport
acetylcholin
cholinerg
agent
stimul
ciliari
activ
wherea
anticholinerg
drug
atropin
hyoscin
inhibit
ciliari
activ
mucociliari
transport
substanc
may
alter
deposit
inhal
particl
lung
sturgess
clara
cell
noncili
bronchiolar
cell
locat
bronchiolar
epithelium
first
describ
clara
small
cylindr
shape
highli
infold
nuclei
surfac
microvilli
well
develop
golgi
abund
endoplasm
reticulum
characterist
oval
homogen
electrondens
granul
apic
cytoplasm
rat
rabbit
man
granul
pasposit
although
usual
consid
pasneg
hamster
mous
dorman
basi
ultrastructur
cytochemistri
use
frozen
thin
section
order
preserv
clara
cell
granul
surfactanttyp
protein
partial
complet
ident
secret
type
ii
pneumocyt
identifi
clara
cell
rat
immunereact
greatest
cytoplasm
granul
also
shown
golgi
endoplasm
reticulum
suggest
surfactanttyp
apoprotein
synthesis
secret
clara
cell
clara
cell
also
highli
activ
metabol
contain
cytochrom
enzym
laboratori
rodent
conduct
airway
termin
abruptli
noncartilagin
nonalveolar
termin
bronchiol
open
directli
alveolar
airway
alveolar
duct
turn
commun
alveoli
bal
ghoshal
squamou
epitheli
type
cell
form
lung
cell
line
alveolar
surfac
virtu
extrem
long
cytoplasm
extens
principl
ga
exchang
take
place
across
cell
rat
typic
thick
barrier
nm
cytoplasm
extens
type
pneumocyt
nm
basal
lamina
nm
endotheli
cell
dorman
type
cell
contain
juxtanuclear
mitochondria
long
smooth
cytoplasm
extens
contain
mani
ribosom
pinocytot
vesicl
anatom
configur
function
type
cell
render
highli
vulner
inhal
gase
particl
main
alveolar
line
cell
granular
pneumocyt
type
ii
cell
constitut
lung
cell
cover
alveolar
surfac
pinkerton
et
al
cell
possess
long
cytoplasm
process
typic
type
cell
show
mani
microvilli
lumin
surfac
cell
cytoplasm
contain
rough
endoplasm
reticulum
golgi
apparatu
mitochondria
characterist
oval
osmiophil
lamellar
inclus
surfact
microaggreg
phospholipid
protein
modifi
alveolar
surfac
tension
low
inflat
volum
secret
type
ii
alveolar
cell
ultrastructur
immunocytochemistri
shown
presenc
surfact
apoprotein
synthet
organel
lamellar
bodi
cell
agreement
concept
surfact
apoprotein
synthesis
rough
endoplasm
reticulum
glycosyl
golgi
store
lamellar
bodi
type
ii
cell
resist
damag
effect
xenobiot
unlik
type
cell
retain
abil
undergo
mitot
divis
follow
damag
type
cell
increas
number
mitos
evid
type
ii
cell
result
appear
larg
undifferenti
epitheli
cell
ultim
differenti
type
type
ii
cell
dorman
alveolar
brush
cell
type
iii
cell
cell
disput
function
describ
rodent
man
constitut
lung
cell
pyramid
cell
locat
princip
junction
septa
microvil
brush
border
surfac
neurosecretori
cell
kultschitski
apud
cell
locat
epitheli
surfac
larynx
trachea
bronchi
bronchiol
alveoli
becker
gazdar
cell
oval
cuboid
oval
nuclei
argyrophil
cytoplasm
electron
microscop
examin
show
contain
dens
core
granul
role
neuroendocrin
cell
lung
uncertain
immunocytochem
studi
shown
contain
neuronespecif
enolas
varieti
peptid
similar
vasoact
intestin
peptid
bombesin
calcitonin
serotonin
leuencephalin
acth
becker
gazdar
sturgess
cell
line
bronchi
bronchiol
alveolar
wall
also
capabl
metabolis
xenobiot
immunocytochem
studi
shown
presenc
immunereact
cytochrom
nadph
cytochrom
reductas
epoxid
hydroxylas
glutathion
stransferas
bronchial
epitheli
cell
ciliat
bronchiolar
cell
clara
cell
type
ii
possibl
type
pneumocyt
rat
lung
baron
et
al
baron
colleagu
show
differ
cell
popul
contain
differ
amount
enzym
clara
cell
contain
greatest
concentr
phenobarbitoneinduc
isoenzym
cytochrom
nadphcytochrom
reductas
epoxid
hydrolas
studi
microsom
enzym
activ
suggest
lung
tissu
contain
fewer
isoenzym
liver
princip
form
smith
brain
wherea
enzym
activ
highli
concentr
specif
cell
type
overal
microsom
enzym
activ
low
compar
liver
per
gram
microsom
protein
smith
brain
pulmonari
microsom
mix
function
oxidas
induc
differ
degre
cigarett
smoke
variou
mous
strain
abramson
hutton
import
cell
pulmonari
alveolar
macrophag
lymphocyt
lymphocyt
found
epithelium
airway
interstitium
alveoli
part
follicl
bronchial
wall
pulmonari
macrophag
form
part
specif
human
immun
defenc
system
lung
involv
elsewher
bodi
antigen
present
rat
mous
distinct
popul
pulmonari
macrophag
describ
base
enzym
activ
reactiv
monoclon
antibodi
monocyt
macrophag
surfac
determin
van
de
breel
et
al
bronchu
associ
macrophag
rat
mous
acid
phosphatas
less
nonspecif
esteras
activ
popul
found
pulmonari
alveoli
interstiti
tissu
import
aspect
immun
system
bronchusassoci
lymphoid
tissu
balt
form
part
mucos
lymphoid
system
found
epithelia
notabl
gastrointestin
tract
morpholog
balt
use
guid
natur
degre
immun
stimulu
react
lung
structur
balt
organis
way
characterist
peripher
lymphoid
organ
organis
function
well
studi
laboratori
rat
close
resembl
balt
laboratori
anim
speci
includ
mous
rabbit
guinea
pig
well
man
bienenstock
et
al
van
der
bruggegamelkoorn
kraal
breel
et
al
size
promin
speci
straindepend
well
function
degre
antigen
stimulu
rat
balt
compos
lymphoid
aggreg
follicl
locat
mostli
bronchu
arteri
zone
lymphocyt
situat
immedi
bronchial
epithelium
peripher
lymphoid
tissu
balt
organis
band
tcell
zone
predetermin
manner
immunocytochem
stain
shown
band
tlymphocyt
zone
differ
locat
one
aggreg
anoth
rat
balt
shown
two
lymphocyt
everi
three
b
cell
compar
ratio
rat
peyer
particl
ratio
may
differ
speci
rabbit
equal
percentag
b
cell
found
balt
peyer
patch
rudzik
et
al
quantit
observ
tcell
subset
use
monoclon
antibodi
clone
mrc
also
shown
rat
balt
contain
twice
mani
thelper
tsuppressorcytotox
lymphocyt
van
der
cell
confin
one
two
discret
zone
light
scatter
cell
within
bcell
zone
immedi
bronchial
epithelium
number
appear
correl
differ
number
b
lymphocyt
enter
lymphoid
aggreg
high
endotheli
venul
bind
assay
shown
differ
adher
specif
high
endotheli
venul
rat
balt
compar
mesenter
lymphoid
tissu
van
der
bruggegamelkoorn
kraal
common
lymph
node
iaposit
interdigit
cell
found
tcell
zone
balt
view
express
ia
antigen
demonstr
rat
use
mous
monoclon
antibodi
mrc
van
der
bcell
zone
interdigit
cell
also
found
demonstr
rat
balt
lymph
node
use
mous
monoclon
mrc
van
der
epithelium
overli
balt
show
anatom
modif
compos
ciliat
noncili
cell
cover
microvilli
convent
untreat
laboratori
rat
balt
show
littl
activ
germin
centr
usual
absent
although
balt
recent
report
promin
rat
coloni
associ
nonspecif
inflammatori
lesion
lung
ewel
mahler
slaoui
et
al
balt
also
present
germfre
anim
although
less
pronounc
convent
rat
bienenstock
et
al
young
wistar
rat
studi
van
der
bruggegamelkoorn
et
al
germin
centr
seen
balt
untreat
anim
develop
follow
administr
singl
intratrach
dose
lipopolysaccharid
tcellindepend
antigen
singl
intratrach
dose
tcelldepend
antigen
horseradish
peroxidas
bovin
serum
albumin
bcg
produc
minor
morpholog
chang
includ
expans
zone
lymphocyt
immedi
epithelium
infiltr
bronchial
epithelium
overli
balt
lymphocyt
addit
perivascular
peribronchi
alveolar
infiltr
small
larg
lymphocyt
macrophag
observ
lung
rat
given
bcg
immunocytochem
studi
rat
balt
follow
intratrach
challeng
horseradish
peroxidas
show
major
cell
infiltr
bronchial
epithelium
helper
posit
lymphocyt
van
der
bruggegamelkoorn
et
al
furthermor
ia
express
epitheli
cell
overli
balt
shown
increas
associ
electron
microscop
evid
increas
number
size
microvilli
pronounc
glycocalyx
decreas
number
size
cilia
immunocytochem
studi
balt
tissu
mice
use
monoclon
antibodi
lymphoid
macrophag
popul
demonstr
quit
similar
arrang
cell
rat
major
cell
belong
helper
posit
class
breel
et
al
pulmonari
lymphat
system
drain
mediastin
cervic
lymph
node
although
among
rat
strain
differ
locat
lymph
node
drainag
pattern
occur
tracer
studi
fischer
rat
use
colloid
carbon
shown
lung
lymphat
drain
mainli
posterior
mediastin
lymph
node
tracheal
wall
drain
primarili
intern
jugular
posterior
cervic
node
takahashi
patrick
mechan
lung
damag
occur
man
alway
clear
particularli
interstiti
lung
diseas
includ
relat
drug
therapi
certain
circumst
initi
insult
may
trigger
whole
cascad
immunemedi
phenomena
lead
chronic
lung
diseas
experiment
evid
suggest
complement
import
sourc
mediat
induct
acut
pulmonari
inflamm
johnson
et
al
stimul
alveolar
macrophag
neutrophil
phagocytosi
chemotax
factor
increas
product
enzym
potenti
hydrolys
elastin
collagen
probabl
neutrophil
import
effector
cell
igg
immun
complexinduc
lung
injuri
iga
immun
complex
appear
capabl
produc
lung
injuri
rat
stimul
oxygen
radic
format
macrophag
johnson
et
al
shown
lymphocyt
capabl
induc
vascular
injuri
lung
anderson
et
al
lymphocyt
import
develop
granulomat
pneumon
induc
mous
bcg
takizawa
et
al
although
varieti
fixat
embed
stain
procedur
avail
light
electron
microscop
examin
lung
tissu
substitut
initi
care
visual
inspect
lung
autopsi
uneven
collaps
lung
open
thorac
caviti
discolor
alter
textur
pleural
cut
surfac
congest
presenc
fluid
larger
airway
may
indic
structur
damag
rodent
lung
small
pulmonari
adenoma
may
detect
inspect
good
light
fresh
lung
weight
also
help
measur
lung
assess
although
passiv
vascular
engorg
significantli
affect
valu
nevertheless
studi
normal
fischer
rat
shown
exsanguin
wet
lung
weight
show
close
relationship
bodi
weight
dri
weight
lung
consist
repres
wet
weight
regardless
age
bodi
weight
suggest
increas
wet
weight
dri
weight
good
index
pulmonari
oedema
howev
pulmonari
transud
exud
protein
rich
dri
lung
weight
may
also
increas
variabl
extent
increas
pulmonari
fluid
nemeri
et
al
variou
method
fixat
employ
although
simpl
immers
fixat
formalin
convent
light
microscopi
virtu
simplic
avoid
risk
transloc
remov
exud
airway
alveoli
mixtur
formaldehyd
paraformaldehyd
glutaraldehyd
use
initi
fixat
electron
microscopi
tyler
et
al
better
appreci
lung
architectur
achiev
instil
fix
via
trachea
appropri
constant
pressur
perfus
fixat
pulmonari
arteri
less
liabl
dislodg
intraalveolar
exud
howev
even
care
signific
artefact
result
airway
instil
vascular
perfus
fixat
michel
sampl
procedur
import
aspect
histolog
examin
bronchi
lung
particularli
larg
laboratori
anim
extent
histolog
section
convent
toxic
studi
modul
take
account
lesion
found
macroscop
examin
type
studi
natur
test
substanc
bronchi
care
sampl
allow
assess
alter
bronchial
epithelium
morphometr
analysi
repres
sensit
tool
great
valu
evalu
druginduc
lung
chang
requir
particularli
rigor
sampl
evalu
procedur
hyde
et
al
tier
multipl
stage
cascad
sampl
techniqu
normal
consid
appropri
morphometr
studi
barri
crapo
involv
divid
lung
seri
homogen
compart
strata
randomli
select
sampl
examin
appropri
light
electron
microscop
techniqu
immunocytochemistri
enzym
cytochemistri
help
studi
heterogen
cell
popul
lung
xenobiot
metabolis
activ
studi
enzym
cytochem
method
well
immunocytochem
techniqu
use
antisera
specif
pulmonari
monooxygenas
relat
enzym
import
structur
compon
particularli
collagen
laminin
studi
light
ultrastructur
level
immunocytochem
method
gil
martinezhernadez
cytokeratin
immunocytochemistri
also
use
method
characteris
chang
epitheli
cell
schlage
et
al
endotheli
cell
fischer
rat
pulmonari
vasculatur
may
demarc
immunocytochem
antisera
factor
viiirel
antigen
help
studi
chang
lung
endothelium
although
may
reliabl
stain
endotheli
cell
organ
see
integumentari
system
chapter
use
antigen
demonstr
lung
includ
surfact
lysozym
immunoglobulin
microorgan
infect
lung
linniola
petrusz
pulmonari
oedema
compon
mani
inflammatori
condit
lung
includ
induc
infect
agent
howev
term
oedema
reserv
poorli
cellular
exud
characteris
presenc
pale
homogen
eosinophil
materi
alveoli
sometim
associ
similar
exud
lung
septa
perivascular
connect
tissu
rather
inflammatori
exud
occur
number
spontan
condit
congest
cardiac
failur
accompani
metastat
pulmonari
neoplasm
agon
chang
associ
pulmonari
congest
haemorrhag
drug
may
induc
cardiogen
pulmonari
oedema
consequ
pulmonari
hypertens
impair
ventricular
contractil
cardiogen
oedema
often
associ
vascular
congest
red
blood
cell
haemoglobin
may
leak
airspac
give
rise
presenc
haemoglobin
crystal
within
oedema
fluid
formalin
fix
tissu
section
fig
importantli
pulmonari
oedema
may
manifest
acut
lung
injuri
inhal
system
administr
toxic
chemic
may
produc
acut
pulmonari
oedema
substanc
phenylthiourea
produc
massiv
pulmonari
oedema
laboratori
anim
administ
oral
princip
result
damag
endothelium
pulmonari
capillari
venul
keher
kacew
drug
report
produc
noncardiogen
pulmonari
oedema
human
either
directli
poorli
understood
immunogen
mechan
holling
anoth
form
pulmonari
oedema
involv
main
airway
precipit
allerg
reaction
sensitis
airway
asthmat
individu
believ
result
crosslink
ige
activ
mast
cell
degranul
releas
inflammatori
mediat
holgat
et
al
shown
occur
main
airway
rat
sensitis
ovalbumin
challeng
ovalbumin
intratrach
rout
lebargi
et
al
treatment
lead
rapid
accumul
bronchial
exud
degranul
mast
cell
develop
mucos
oedema
mark
immedi
respiratori
epithelium
congest
haemorrhag
frequent
find
lung
laboratori
anim
usual
relat
certain
mode
death
associ
administr
drug
chemic
advers
effect
cardiac
function
coagul
system
administr
heparin
rat
produc
characterist
extravas
blood
air
space
larsen
et
al
lower
respiratori
tract
infect
gener
major
health
hazard
among
laboratori
anim
nevertheless
everpres
threat
caus
overt
respiratori
diseas
within
coloni
develop
follow
administr
xenobiot
subclin
pulmonari
infect
infest
also
produc
histolog
alter
bronchial
airway
pulmonari
parenchyma
mimic
chang
induc
inhal
irrit
system
administ
drug
elwel
mahler
slaoui
et
al
furthermor
respiratori
pathogen
alter
immun
defenc
exacerb
effect
inhal
substanc
jakab
rang
bacteri
viral
pathogen
may
produc
inflammatori
lung
chang
everitt
richter
typic
bacteri
pathogen
streptococcu
pneumonia
produc
acut
bronchiti
associ
variabl
degre
acut
inflamm
lung
parenchyma
bronchopneumonia
confluent
lobar
pneumonia
viral
agent
gener
associ
histolog
featur
bronchiol
interstiti
pneumonia
characteris
increas
mononuclear
cell
respiratori
bronchiol
alveolar
septa
histolog
featur
variabl
depend
particular
pathogen
speci
strain
immun
statu
presenc
absenc
secondari
infect
particular
stage
infect
examin
respiratori
infect
frequent
mix
chang
due
secondari
bacteri
infect
frequent
superimpos
induc
virus
sequenti
histopatholog
examin
lung
laboratori
anim
follow
inocul
respiratori
tract
pathogen
abl
characteris
evolut
patholog
chang
produc
individu
organ
instanc
rat
infect
mycoplasma
pulmoni
one
import
intercurr
respiratori
pathogen
among
laboratori
rodent
follow
inocul
lew
rat
shown
develop
upper
lower
respiratori
tract
inflammatori
process
lew
strain
characteris
day
variabl
acut
inflammatori
exud
bronchi
bronchiol
focal
bronchiectasi
inflamm
hyperplasia
epithelium
predomin
macrophag
infiltr
alveoli
aveolar
wall
davi
cassel
chang
associ
mark
hyperplasia
bronchusassoci
lymphoid
tissu
balt
extend
airway
blood
vessel
toward
peripheri
lung
although
lymphoid
hyperplasia
also
found
inocul
rat
less
mark
accompani
littl
mucopurul
exud
activ
inflamm
bronchial
wall
similar
studi
conduct
rat
mice
infect
anoth
import
respiratori
pathogen
laboratori
rodent
sendai
viru
parainfluenza
type
sequenti
studi
show
initi
damag
bronchial
bronchiolar
epithelium
associ
polymorphonuclear
lymphocyt
inflamm
bronchiol
immunocytochem
ultrastructur
studi
reveal
presenc
viral
antigen
mucosa
jakab
hyperplast
multinucl
syncyti
epitheli
cell
develop
hyperplast
termin
bronchiolar
epithelium
inflammatori
process
extend
involv
peribronchi
peribronchiolar
parenchyma
infiltr
alveolar
wall
mononuclear
cell
macrophag
neutrophil
similar
cell
popul
accompani
cell
debri
oedema
fluid
develop
air
space
pulmonari
arteri
show
minor
involv
inflammatori
cell
focal
reactiv
hyperplasia
endothelium
immunocytochemistri
ultrastructur
examin
suggest
viru
replic
take
place
alveolar
type
type
ii
epitheli
cell
macrophag
endotheli
interstiti
cell
alveolar
septa
castleman
et
al
shown
repair
occur
may
residu
distort
bronchiolar
alveolar
wall
collagen
increas
tumour
necrosi
express
shown
import
regulatori
factor
develop
sendai
virusinduc
bronchiolar
fibrosi
infect
rat
uhi
et
al
hyperplast
cuboid
epithelium
may
line
thicken
alveolar
septa
air
space
contain
enlarg
macrophag
pale
vacuol
cytoplasm
castleman
corona
viru
caus
sialodacryoaden
mani
rat
coloni
also
produc
lower
respiratori
tract
inflamm
characteris
acut
bronchiti
bronchiol
focal
extens
lung
parenchyma
thicken
oedemat
hypercellular
alveolar
wall
infiltr
monocyt
cell
found
wojcinski
perci
immunocytochemistri
shown
presenc
viral
antigen
bronchial
bronchiolar
epitheli
cell
also
peribronchi
lymphocyt
infiltr
increas
promin
balt
ultim
complet
resolut
occur
virus
remain
potenti
sourc
spontan
respiratori
diseas
laboratori
dog
canin
adenoviru
type
parainfluenza
canin
herp
viru
coronaviru
parvoviru
isol
laboratori
dog
develop
respiratori
diseas
binn
et
al
castleman
show
evolut
histolog
chang
antigen
localis
lung
young
beagl
dog
experiment
inocul
canin
adenoviru
type
syndrom
viscer
larva
migran
also
incit
focal
inflamm
granuloma
fibrosi
lung
speci
dog
primat
parasit
preval
syndrom
viscer
larva
migran
usual
defin
result
migrat
nematod
larva
viscera
well
describ
beagl
dog
lung
result
larva
toxocara
speci
metastrongyloid
nematod
barron
saunder
hirth
hottendorf
precis
identif
parasit
alway
possibl
tissu
section
histolog
appear
infest
lung
highli
variabl
nematod
surround
granuloma
granulomat
inflamm
mostli
subpleur
locat
may
visibl
section
affect
lung
may
perivascul
activ
arteriol
bronchiol
peribronchiol
pleural
involv
inflammatori
process
mark
particularli
region
overli
granuloma
scar
develop
pleural
subpleur
fibrosi
frequent
associ
epitheli
hyperplasia
squamou
metaplasia
associ
airway
hirth
hottendorf
lesion
may
suffici
mark
resembl
induc
high
dose
anticanc
drug
bleomycin
see
pulmonari
acariasi
common
infest
mani
speci
nonhuman
primat
caus
variou
speci
mite
pneumonyssu
reproduct
mite
appear
take
place
termin
bronchiol
pneumonyssu
simicola
recognis
form
found
rhesu
monkey
kim
although
preval
wild
caught
primat
diseas
easili
elimin
breed
captiv
joseph
et
al
mite
produc
signific
destruct
pulmonari
patholog
render
anim
suscept
secondari
pulmonari
bacteri
infect
disrupt
confound
interpret
toxic
studi
perform
primat
lesion
locat
frequent
cranial
lobe
characteris
presenc
bulla
distend
pleural
surfac
parenchym
cyst
nodul
scar
joseph
et
al
kim
histolog
wide
rang
inflammatori
activ
fulli
develop
lesion
characteris
granulomat
bronchiol
peribronchiol
involv
immedi
adjac
alveoli
cystic
lesion
involv
bronchiolar
wall
develop
around
parasit
give
rise
appear
walledoff
cyst
compos
highli
cellular
granul
tissu
associ
neutrophil
lymphocyt
macrophag
multinucl
giant
cell
variou
pigment
see
less
activ
lesion
dilat
cystic
airway
wall
compos
thick
band
smooth
muscl
line
squamou
cuboid
epithelium
found
joseph
et
al
pneumocysti
carinii
import
caus
pneumonia
patient
acquir
immunodefici
syndrom
aid
well
immunocompromis
patient
includ
treat
immunosuppress
drug
walzer
natur
habitat
pneumocysti
carinii
pulmonari
alveoli
wide
encount
human
popul
without
associ
overt
diseas
clinic
experiment
evid
suggest
impair
cellular
immun
much
import
predispos
factor
impair
humor
immun
walzer
man
laboratori
anim
may
latent
pneumocysti
infect
becom
clinic
evid
follow
immunosuppress
shown
rat
chronic
administr
variou
regimen
adenocorticosteroid
low
protein
diet
cyclophosphamid
immunosuppress
drug
concomit
antibiot
administr
prevent
infect
give
rise
typic
pneumocysti
pneumonia
chandler
et
al
rodent
genet
defici
cellular
immun
also
develop
pneumocysti
pneumonia
import
pneumocysti
pneumonia
toxicolog
consid
sentinel
chronic
immun
depress
haematoxylin
eosin
stain
section
pneumocysti
pneumonia
characteris
man
rodent
presenc
alveoli
fill
foami
eosinophil
materi
contain
macrophag
indistinct
nuclei
pneumocysti
fig
ovoid
crescentshap
structur
organ
becom
clearli
visibl
gomori
methenamin
silver
toluidin
blue
stain
ultrastructur
studi
rat
pneumocysti
pneumonia
show
trophozoit
attach
frequent
type
pneumocyt
alter
morpholog
contour
pneumocyt
rather
process
invas
long
et
al
system
administ
therapeut
agent
may
produc
histolog
chang
within
lung
parenchyma
mimic
compon
normal
respons
respiratori
pathogen
howev
sharp
separ
agent
produc
pulmonari
oedema
associ
acut
inflammatori
chang
histolog
featur
overlap
acut
inflammatori
process
often
accompani
exud
within
airspac
exampl
druginduc
pulmonari
inflamm
laboratori
anim
human
report
follow
administr
glycoprotein
lymphokin
molecular
weight
normal
produc
activ
cell
mediat
immunoregulatori
respons
produc
larg
quantiti
recombin
dna
technolog
use
tumour
immunotherapi
high
dose
associ
number
advers
effect
notabl
vascular
leak
syndrom
syndrom
characteris
clinic
pulmonari
oedema
pleural
effus
ascit
rosenberg
et
al
vascular
leak
syndrom
report
laboratori
anim
given
high
dose
agent
histolog
examin
lung
mice
develop
syndrom
follow
administr
show
infiltr
alveolar
wall
larg
lymphocyt
intraalveolar
proteinac
exud
contain
larg
lymphocyt
macrophag
red
blood
cell
anderson
et
al
pulmonari
venul
arteriol
also
show
presenc
lymphocyt
attach
lie
beneath
endothelium
infiltr
vessel
wall
perivascular
locat
accompani
oedema
fluid
red
blood
cell
similar
less
sever
chang
demonstr
rat
given
anderson
hay
addit
treat
rat
show
infiltr
pulmonari
vasculatur
eosinophil
probabl
secondari
eosinopoiet
cytokin
produc
stimul
lymphocyt
immunocytochem
evalu
lymphoid
infiltr
mice
show
cell
thi
lymphocyt
furthermor
coadministr
asialo
gangliontetrosylceremid
abrog
clinic
sign
also
reduc
number
asialo
lymphocyt
tissu
section
lymphoid
cell
express
suppressorcytotox
cell
unaffect
asialo
treatment
postul
vascular
leak
syndrom
antitumour
efficaci
mice
mediat
endogen
subset
stimul
lymphocyt
lymphokineactiv
killer
cell
anderson
et
al
correspond
chang
also
observ
liver
lymphoid
tissu
see
liver
chapter
viii
haemopoiet
lymphat
system
chapter
iii
recent
immunocytochem
detail
electron
microscop
studi
rat
support
concept
induc
cytotox
vascular
damag
mediat
directli
lymphokineactiv
killer
cell
cytotox
lymphocyt
secondari
releas
inflammatori
cytokin
zhang
et
al
man
sever
chronic
pulmonari
inflammatori
diseas
laboratori
anim
may
compromis
pulmonari
function
lead
secondari
alter
organ
although
mechan
explor
detail
diffus
interstiti
pulmonari
inflammatori
process
lung
haemorrhag
induc
rat
treat
year
prizidilol
sk
f
antihypertens
agent
vasodil
block
properti
sutton
et
al
affect
anim
develop
dyspnoea
associ
reduct
lung
volum
deform
thorac
spinal
column
mark
cardiac
hypertrophi
inflamm
granulomat
compon
develop
lung
laboratori
anim
varieti
differ
circumst
allud
granuloma
may
found
without
obviou
causat
common
caus
rodent
respons
accident
inhal
foreign
bodi
lipid
granuloma
cholesterol
cleft
fibrosi
develop
focal
respons
lipid
releas
foami
macrophag
accumul
rat
increas
age
druginduc
phospholipidosi
dog
primat
liabl
infest
parasit
granulomat
inflamm
respons
pulmonari
larva
common
speci
anoth
form
granulomat
pulmonari
inflamm
result
aspir
stomach
content
food
particl
aspir
pneumonia
sporad
observ
age
rat
associ
gener
illhealth
particularli
result
pressur
effect
larg
pituitari
adenoma
subsequ
disturb
pharyng
laryng
reflex
mechan
dixon
jure
histolog
lung
show
peribronchi
peribronchiolar
granulomat
inflamm
macrophag
foreign
bodi
cell
associ
fragment
refractil
veget
matter
associ
bronchial
mucosa
may
also
show
reactiv
chang
includ
goblet
cell
hyperplasia
longstand
case
pulmonari
tuberculosi
repres
potenti
problem
among
nonhuman
primat
coloni
view
insidi
onset
liabil
transmiss
monkey
man
wolf
et
al
patholog
find
similar
well
known
human
diseas
diseas
characteris
presenc
granuloma
lung
parenchyma
lymph
node
florid
case
may
caseat
surround
epithelioid
multinucl
giant
cell
variabl
number
lymphocyt
plasma
cell
fibroblast
diffus
granulomat
pneumonia
result
tuberculosi
also
report
nonhuman
primat
wolf
et
al
granulomat
pneumon
produc
laboratori
anim
intraven
inject
bcg
twentyeight
day
follow
intraven
inject
bcg
lung
mice
contain
numer
granuloma
compos
histiocyt
round
cell
surround
alveoli
thicken
wall
associ
mild
interstiti
pneumon
takizawa
histolog
chang
associ
increas
number
thi
cell
especi
posit
lymphocyt
histolog
chang
abrog
treatment
cyclosporin
suggest
import
role
lymphocyt
develop
granuloma
discret
granuloma
occur
lung
experiment
anim
respons
intrach
intraven
inject
certain
rel
insolubl
substanc
intrach
administr
insolubl
polymeris
dextran
latex
microparticl
mice
show
morpholog
system
effect
granuloma
depend
natur
inject
substanc
larg
granuloma
rapidli
develop
pulmonari
parenchyma
around
dextran
particl
subsequ
regress
quit
quickli
wherea
latex
particl
produc
small
discret
stabl
granuloma
allr
et
al
although
form
granuloma
foreign
bodi
nonimmunolog
type
produc
dextran
latex
bead
associ
anergylik
immunosuppress
probabl
caus
releas
solubl
factor
granuloma
report
granuloma
format
instil
sephadex
bead
associ
increas
like
activ
lung
kasahara
et
al
studi
compar
effect
inhal
crystallin
silica
titanium
dioxid
shown
correl
releas
macrophag
deriv
cytokin
granuloma
format
driscol
maurer
consequ
worker
suggest
might
use
biomark
granuloma
format
localis
angiocentr
granuloma
foreign
bodi
type
cluster
around
pulmonari
arteri
arteriol
occasion
alveolar
capillari
venul
also
develop
follow
intraven
inject
rel
insolubl
polysaccharid
polym
jonson
et
al
characterist
epithelioid
larg
foreign
bodi
type
giant
cell
effac
smaller
vessel
although
overt
necrosi
usual
observ
fig
haemosiderinladen
macrophag
accumul
alveoli
laboratori
anim
associ
chronic
pulmonari
congest
haemorrhag
similar
chang
occur
man
particularli
congest
cardiac
failur
haemosiderinladen
macrophag
frequent
term
heart
failur
cell
lung
nonhuman
primat
especi
liabl
contain
alveolar
perivascular
peribronchi
aggreg
macrophag
laden
variou
brown
pigment
ironcontain
pigment
associ
inflammatori
chang
produc
simian
lung
mite
pneumonyssu
simicola
preval
mani
nonhuman
primat
addit
lung
primat
coloni
may
show
perivascular
peribronchi
collect
browngrey
macrophag
contain
highli
refract
spicul
plate
compos
high
concentr
silica
dayan
et
al
kim
cole
shown
old
world
primat
includ
rhesu
cynomolog
monkey
pigment
contain
fossil
diatomac
materi
compat
concept
anim
inhal
dust
contain
diatom
silicon
fragment
expos
semiarid
natur
habitat
dayan
et
al
chronic
lung
injuri
varieti
differ
caus
frequent
associ
develop
pulmonari
fibrosi
characteris
replac
normal
pulmonari
structur
thicken
collagen
matrix
consequ
reduct
capac
ga
exchang
regardless
incit
agent
agent
fibrogen
process
appear
gener
characteris
disrupt
normal
alveolarcapillari
structur
leakag
exud
vascular
compart
airspac
subsequ
invas
inflammatori
cell
fibroblast
excess
matrix
format
studi
laboratori
anim
differ
fibrogen
agent
well
human
suggest
central
pulmonari
fibrogenesi
increas
product
tumour
necrosi
macrophag
phan
kunkel
driscol
et
al
piguet
vesin
warheit
et
al
uhl
et
al
cytokin
mitogen
fibroblast
also
potent
activ
chemoattract
macrophag
capabl
stimul
releas
cytokin
induc
express
adhes
molecul
express
endotheli
cell
derynck
warheit
et
al
uhl
et
al
moreov
shown
receptor
knockout
mice
appear
protect
fibroprolif
effect
inhal
asbesto
liu
et
al
pulmonari
fibrosi
common
sequel
chronic
lower
respiratori
tract
inflamm
may
associ
preced
interstiti
pneumon
characteris
infiltr
lymphocyt
plasma
cell
macrophag
scatter
polymorphonuclear
cell
singer
et
al
focal
pulmonari
fibrosi
occur
spontan
laboratori
anim
although
usual
preval
dog
nonhuman
primat
respons
chronic
infest
parasit
easili
elimin
breed
man
condit
lead
pulmonari
fibrosi
vari
wide
includ
infect
shock
lung
syndrom
ionis
radiat
inhal
irrit
particul
matter
exposur
antigen
excess
amount
oxygen
well
result
toxic
paraquat
rang
cytotox
noncytotox
therapeut
agent
caus
pulmonari
parenchym
injuri
johnson
et
al
holling
principl
therapeut
agent
produc
pulmonari
fibrosi
man
laboratori
anim
anticanc
drug
bleomycin
glycopeptid
prepar
deriv
streptomyc
verticillu
best
known
exampl
pulmonari
fibrosi
also
associ
clinic
use
number
anticanc
agent
includ
bcnu
carmustin
cyclophosphamid
busulphan
mitomycin
c
methotrex
gutin
et
al
weiss
muggia
kehrer
kacew
holling
malik
et
al
wide
rang
noncytotox
drug
also
report
produc
pulmonari
fibrosi
human
holling
tomioka
king
precis
mechan
involv
induct
pulmonari
fibrosi
antineoplast
drug
man
poorli
understood
true
incid
particular
drug
also
difficult
estim
confound
factor
cancer
patient
concomit
administr
sever
drug
radiat
oxygen
therapi
diffus
pulmonari
cancer
opportun
infect
probabl
druginduc
fibrosi
accentu
concomit
administr
sever
antineoplast
agent
radiat
therapi
hyperoxia
preexist
pulmonari
damag
age
patient
sever
often
relat
total
dose
drug
receiv
kehrer
kacew
bleomycin
associ
develop
interstiti
pneumonia
pulmonari
fibrosi
clinic
use
luna
et
al
also
induc
experiment
anim
histopatholog
appear
bleomycininduc
pulmonari
fibrosi
patient
mani
instanc
differ
seen
laboratori
anim
lung
patient
treat
beomycin
modifi
factor
primari
neoplast
diseas
multipl
drug
radiat
therapi
well
secondari
pulmonari
infect
interstiti
pneumon
fibrosi
postul
import
mediat
develop
bleomycininduc
fibrosi
piquet
vesin
beagl
dog
given
cycl
bleomycin
intraven
rout
period
week
develop
anorexia
weight
loss
varieti
epitheli
lesion
well
focal
interstiti
pneumonia
fibrosi
thompson
et
al
dog
studi
report
thompson
et
al
lesion
focal
interstiti
pneumonia
fibrosi
characteris
increas
elast
fibr
reticulin
collagen
acid
mucosubst
lesion
situat
predominantli
pleural
subpleur
zone
suggest
potenti
effect
friction
pleural
surfac
histolog
lesion
resembl
produc
larva
migran
dog
similar
histolog
chang
also
describ
rat
mice
treat
bleomycin
intraven
intratrach
rout
thrall
et
al
lindenschmidt
et
al
fibrosi
consist
chang
bleomycintr
rodent
extens
employ
model
pulmonari
fibrosi
earli
chang
includ
mild
diffus
increas
interstiti
lymphocyt
macrophag
polymorphonuclear
cell
perivascular
interstiti
oedema
week
interstiti
infiltr
also
compris
fibroblast
earli
collagen
deposit
associ
prolifer
macrophag
type
ii
pneumocyt
thrall
et
al
lindenschmidt
et
al
subsequ
amount
interstiti
collagen
increas
eventu
scar
collaps
lung
tissu
proport
cumul
dose
given
brown
et
al
immunohistochem
ultrastructur
studi
rat
mice
treat
bleomycin
show
larg
accumul
immunereact
laminin
redupl
basement
lamina
within
thicken
alveolar
wall
singer
et
al
bleomycintr
rat
chang
pulmonari
capillari
structur
demonstr
threedimension
scan
electron
microscopi
treatment
produc
irregular
alveolar
pleural
capillari
increas
diamet
decreas
branch
schraufnagel
et
al
certain
strain
mice
shown
possess
greater
sensit
bleomycin
fibrogenesi
strain
produc
greater
fibroblast
respons
swiss
mice
balbc
strain
demonstr
particularli
poor
fibroblast
respons
schrier
et
al
therapeut
use
cyclophosphamid
also
occasion
associ
develop
pulmonari
interstiti
fibrosi
weiss
muggia
malik
et
al
appear
associ
two
form
patholog
earlyonset
pneumon
late
onset
progress
pulmonari
fibrosi
malik
et
al
similar
chang
less
easi
reproduc
laboratori
anim
mice
sequenti
examin
period
year
singl
intraven
dose
mgkg
cyclophosphamid
slight
pulmonari
interstiti
thicken
hypercellular
observ
associ
progress
multifoc
accumul
intraalveolar
macrophag
mors
et
al
howev
chang
also
accompani
progress
increas
pulmonari
hydroxyprolin
content
decreas
pulmonari
complianc
time
treat
anim
compar
control
chang
amplifi
exposur
ambient
oxygen
bronchiol
alveolar
septal
inflamm
fibrosi
induc
gold
therapi
patient
rheumatoid
arthriti
interest
probabl
immunemedi
condit
associ
peripher
eosinophila
druginduc
alter
immun
system
tamoika
king
emphysema
characteris
abnorm
perman
enlarg
airspac
distal
termin
bronchiol
accompani
destruct
wall
without
obviou
fibrosi
three
principl
type
centriacinar
panacinar
distal
acinar
emphysema
recognis
man
enlarg
air
space
result
congenit
factor
fibrou
scar
group
separ
regard
true
emphysema
snider
et
al
although
emphysema
occasion
observ
agerel
spontan
chang
laboratori
rodent
levam
sever
experiment
rodent
emphysema
model
develop
use
intratrach
instil
proteolyt
enzym
papain
pancreat
neutrophil
elastas
give
rise
histolog
appear
resembl
panacinar
emphysema
man
elastas
enter
alveolar
wall
via
type
pneumocyt
spread
lung
interstitium
produc
degrad
elastin
fibr
associ
oedema
cellular
exud
elastas
enter
blood
inactiv
clear
pulmonari
circul
eventu
alveolar
exud
clear
air
space
enlarg
occur
see
review
snider
et
al
intraven
administr
elastas
may
also
induc
emphysema
higher
dose
requir
irrit
gase
notabl
oxid
nitrogen
also
capabl
induc
chang
lung
laboratori
rat
hamster
follow
long
term
exposur
resembl
mild
human
centrilobular
emphysema
juho
et
al
lam
et
al
varieti
differ
name
appli
membranebound
acid
phosphataseposit
cytoplasm
inclus
lamella
crystalloid
ultrastructur
matrix
includ
myeloid
bodi
myelinoid
bodi
myelin
figur
myelinosom
lysosom
inclus
seen
small
number
varieti
normal
cell
type
accumul
variou
organ
follow
administr
wide
varieti
xenobiot
characterist
generalis
accumul
cytoplasm
inclus
report
laboratori
anim
follow
repeat
administr
numer
amphiphil
cation
drug
generalis
accumul
lysosom
cytoplasm
bodi
gener
call
phospholipidosi
term
coin
describ
tissu
accumul
phospholipid
shikata
et
al
number
worker
review
drug
caus
phospholipidosi
laboratori
anim
et
al
reasor
holling
halliwel
induc
agent
quit
differ
therapeut
class
usual
share
structur
featur
includ
hydrophil
cation
side
chain
primari
secondari
tertiari
amin
hydrophob
region
usual
aromat
ring
ring
system
structur
pattern
render
molecul
amphiphil
drug
probabl
bind
polar
lipid
mean
electrostat
hydrophob
forc
et
al
lead
format
druglipid
complex
poorli
degrad
lysosom
enzym
accumul
cell
cytoplasm
form
inclus
describ
bind
coval
revers
depend
dissoci
rate
constant
particular
intracellular
condit
drug
concentr
achiev
predict
activ
base
molecular
structur
shown
reason
good
correl
abil
compound
produc
phospholipidosi
cultur
rat
periton
macrophag
correl
less
good
whole
anim
data
evalu
presum
differ
drug
disposit
blood
tissu
actual
exampl
includ
anorect
drug
chlorphentermin
tricycl
antidepress
inhibitor
cholesterol
biosynthesi
triparanol
antihistamin
chlorcyclizin
analogu
antioestrogen
tamoxifen
chloroquin
cardiovascular
drug
amiodaron
perhexilin
et
al
mani
tissu
organ
may
develop
cytoplasm
inclus
includ
lymphoid
cell
liver
pancrea
endocrin
tissu
nervou
system
muscl
cell
eye
particularli
lung
lung
appear
especi
vulner
druginduc
phospholipidosi
possibl
macrophag
close
proxim
bloodborn
agent
reasor
continu
uptak
phospholipidrich
surfact
materi
alveoli
macrophag
lead
excess
accumul
phospholipid
catabol
impair
et
al
fact
lung
commonli
affect
potenti
use
diagnost
featur
mani
organ
phospholipidosi
extrem
difficult
recognis
light
microscopi
haematoxylin
eosinstain
section
although
chang
lung
specif
druginduc
phospholipidosi
increas
number
lipidcontain
lung
macrophag
treat
anim
compar
control
rel
easi
detect
provid
simpl
way
pathologist
screen
effect
sever
generalis
phopholipidosi
rat
lung
show
irregular
pale
grey
yellowish
patch
discolor
pleura
parenchyma
result
patchi
confluent
aggreg
larg
pale
foami
macrophag
free
lie
pack
alveoli
commonli
accompani
granular
extracellular
materi
abund
cytoplasm
show
vacuol
appear
fine
eosinophil
granul
sometim
visibl
nuclei
round
central
locat
structur
variabl
size
multilamin
cell
also
occasion
seen
vacuol
cell
firmli
attach
alveolar
wall
probabl
pneumocyt
foami
cell
stain
typic
phospholipid
eg
acid
haematin
although
neutral
lipid
may
also
present
stain
oil
red
semithin
plastic
embed
section
stain
toluidin
blue
allow
better
characteris
phospholipidosi
organ
includ
lung
macrophag
air
space
contain
unmistak
dens
dark
round
cytoplasm
inclus
variabl
size
mm
diamet
heath
et
al
plastic
embed
section
also
show
inclus
pulmonari
cell
includ
pneumocyt
attach
alveolar
wall
seen
discharg
alveolar
space
organ
affect
phospholipidosi
ultrastructur
examin
reveal
dens
multilamellar
membran
numer
heterogen
dens
bodi
lysosom
origin
bodi
need
distinguish
membran
bodi
form
result
fixat
ultrastructur
studi
lipid
tend
leach
becom
hydrat
form
myelinoid
membran
glutaraldehyd
fixat
structur
subsequ
fix
osmium
give
rise
electrondens
membran
figur
outsid
insid
cell
particularli
mitochondria
may
mistaken
patholog
lesion
ghadial
et
al
robinson
et
al
lamella
pattern
seen
phospholipidosi
may
simpl
altern
dens
clear
line
space
nm
complex
arrang
clear
dens
line
typic
crystalloid
inclus
hexagon
aggreg
tubular
subunit
seen
organ
usual
found
lung
signific
variou
form
uncertain
probabl
repres
variou
phase
phospholipid
exist
influenc
proport
lipid
present
electron
microscop
examin
reveal
pulmonari
macrophag
affect
chang
inclus
may
present
pneumocyt
type
ii
pulmonari
capillari
endotheli
cell
smooth
muscl
cell
bronchiolar
epithelium
occasion
neutrophil
reil
et
al
robinson
et
al
chang
typic
still
visibl
sever
week
withdraw
treatment
offend
agent
although
extent
pulmonari
phospholipidosi
lung
may
vari
dosag
regimen
speci
studi
chlorphentermin
amiodaron
indic
similar
cytolog
ultrastructur
chang
occur
laboratori
anim
speci
studi
includ
rat
mice
hamster
guinea
pig
rabbit
dog
reil
de
la
iglesia
et
al
et
al
et
al
implic
human
drug
induc
phospholipidosi
laboratori
anim
although
agent
produc
phospholipidosi
anim
studi
man
drug
produc
phospholipidosi
anim
capabl
induc
phospholipidosi
human
clinic
practic
holling
agent
chloroquin
amiodaron
shown
produc
phospholipidosi
man
also
induc
frank
cellular
damag
organ
remain
unclear
whether
phenomena
phospholidosi
causal
relat
cellular
damag
human
find
phospholipidosi
anim
studi
novel
drug
requir
care
assess
case
case
basi
respect
implic
safeti
human
exampl
issu
iodin
benzofuran
deriv
amiodaron
potent
antiarrhythm
drug
effect
ventricular
arrhythmia
lung
toxic
continu
problem
patient
treat
cardiac
arrhythmia
drug
phospholipidosi
occur
wide
varieti
organ
laboratori
anim
treat
amiodaron
et
al
riva
et
al
also
liver
peripher
nerv
cell
skin
lymphoid
cell
lung
man
therapeut
dose
et
al
shepherd
et
al
fan
et
al
wherea
phospholipidosi
induc
amiodaron
lung
rodent
associ
fibrosi
signific
function
alter
riva
et
al
heath
et
al
pulmonari
interstiti
fibrosi
occur
associ
phospholipidosi
man
et
al
sever
theori
propos
pulmonari
alveol
interstiti
fibrosi
human
weight
evid
date
suggest
accumul
lipidladen
histiocyt
causal
relat
alveol
pulmonari
fibrosi
reasor
kacew
cytotox
possibl
metabolit
desethylamiodaron
propos
immunemedi
mechan
postul
possibl
favour
bind
drug
compon
pulmonari
tissu
fan
et
al
also
possibl
pulmonari
diseas
result
particular
patient
interact
sever
mechan
metabol
factor
reasor
kacew
despit
undoubt
differ
tissu
speci
sensit
develop
phospholipidosi
dose
drug
disposit
metabol
elimin
degre
tissu
exposur
drug
import
consider
safeti
assess
drug
produc
phospholipidosi
laboratori
anim
although
phospholipidosi
like
occur
high
dose
employ
toxic
studi
lower
therapeut
dose
use
man
suggest
may
offset
faster
elimin
drug
characterist
small
laboratori
anim
et
al
potenti
drug
accumul
critic
tissu
eye
heart
especi
import
drug
administ
long
period
time
particularli
tissueplasma
ratio
amphiphil
drug
may
exceed
follow
repeat
administr
et
al
consequ
implic
human
drug
induc
phospholipidosi
laboratori
anim
assess
case
case
basi
due
consider
mechan
drug
disposit
clinic
riskbenefit
analysi
import
underlin
similar
morpholog
chang
also
result
treatment
compound
cation
amphiphil
structur
exampl
induct
lysosom
inclus
lung
rat
dog
antibiot
erythromycin
gray
et
al
hook
review
rang
agent
increas
phospholipid
level
lung
includ
oxid
gase
insolubl
particl
silica
accumul
foami
macrophag
alveolar
space
also
occur
spontan
chang
age
rat
yang
et
al
contrast
druginduc
chang
spontan
lipidosi
occur
sporad
older
rat
observ
control
treat
anim
druginduc
phospholipidosi
occur
within
period
sever
month
lung
control
anim
remain
fairli
free
spontan
foamcel
accumul
variou
form
hyperplasia
found
airway
lung
laboratori
anim
mucos
surfac
bronchi
may
show
hyperplasia
goblet
cell
squamou
hyperplasia
metaplasia
cell
line
termin
bronchiol
alveolu
may
also
show
hyperplasia
squamou
metaplasia
chang
summaris
rat
classif
societi
toxicolog
pathologist
schwartz
et
al
intern
agenc
research
cancer
mohr
goblet
cell
hyperplasia
well
recognis
respons
mucosa
conduct
airway
chronic
inflamm
inhal
irrit
substanc
cigarett
smoke
sulphur
dioxid
reid
jone
et
al
coggin
et
al
also
report
occur
hamster
emphysema
model
human
neutrophil
elastas
instil
intratrach
rout
christensen
et
al
degre
goblet
cell
hyperplasia
dictat
sever
durat
irrit
inflammatori
process
howev
speci
differ
exist
airway
laboratori
anim
variabl
endow
goblet
cell
submucos
mucou
gland
instanc
normal
rat
goblet
cell
line
airway
either
mous
hamster
reid
florid
case
goblet
cell
hyperplasia
characteris
histolog
thicken
pseudostratif
tracheal
bronchial
mucosa
popul
tall
mucu
secret
cell
abund
pale
cytoplasm
addit
goblet
cell
extend
airway
normal
anim
mucu
may
fill
distend
airway
impact
alveoli
reid
less
florid
case
simpl
increas
number
goblet
cell
may
found
without
structur
chang
coggin
et
al
factor
control
alter
uncertain
suggest
increas
mitot
activ
well
cell
convers
probabl
metaplasia
serou
clara
cell
mucou
cell
involv
bolduc
et
al
christensen
et
al
type
goblet
cell
hyperplasia
line
epithelium
may
accompani
increas
size
underli
submucos
gland
clearli
demonstr
patient
chronic
bronchiti
rat
submucos
gland
normal
quit
promin
reid
reid
spontan
goblet
cell
metaplasia
pulmonari
alveolar
epithelium
describ
rat
localis
mass
compris
distend
alveoli
bronchiol
fill
mucin
line
noncili
epitheli
cell
numer
goblet
cell
presum
development
origin
nagai
pharmacolog
agent
induc
goblet
mucou
cell
hyperplasia
rat
given
daili
inject
isoprenalin
nonselect
agonist
show
doseand
timedepend
increas
number
size
alcian
blueposit
goblet
mucou
cell
well
serou
cell
tracheal
bronchial
mucosa
associ
increas
length
width
depth
submucos
gland
sturgess
reid
similar
chang
produc
pilocarpin
although
alcian
blue
pa
posit
cell
increas
number
follow
agent
suggest
pilocarpin
induc
acid
neutral
glycoprotein
secret
critic
comparison
distribut
chang
rat
follow
isoprenalin
salbutamol
pilocarpin
tobacco
smoke
show
region
differ
distribut
chang
airway
reid
jone
isoprenalin
produc
greater
increas
secretori
cell
peripher
airway
tobacco
smoke
produc
greater
increas
mitot
activ
isoprenalin
pilocarpin
produc
diffus
chang
select
salbutamol
chang
induc
therapeut
agent
presum
result
pharmacolog
activ
reid
jone
sturgess
reid
show
chang
rat
accompani
hypertrophi
pancrea
submaxillari
parotid
salivari
gland
see
digest
system
chapter
vii
unlik
rat
mous
hamster
appear
predispos
develop
minor
multifoc
epitheli
hyperplasia
tracheal
bronchial
mucosa
spontan
advanc
age
chang
flat
polypoid
natur
compos
clear
cell
goblet
cell
pour
et
al
pour
et
al
epithelium
bronchi
show
squamou
metaplasia
respons
chronic
irrit
injuri
characteris
three
layer
epitheli
cell
abund
eosinophil
cytoplasm
promin
cell
boundari
may
associ
degen
alter
mucosa
goblet
cell
hyperplasia
squamou
metaplasia
also
develop
alveolar
parenchyma
also
relat
prolong
damag
produc
larg
burden
inhal
irrit
insolubl
dust
metaplasia
also
characteris
presenc
sever
layer
flatten
epitheli
cell
show
squamou
differenti
classif
cystic
keratinis
lesion
rat
lung
associ
larg
burden
particul
matter
subject
specialist
workshop
boorman
et
al
term
pulmonari
keratinis
cyst
recommend
larg
cystic
lesion
line
nonneoplast
squamou
epithelium
without
excess
prolif
chang
hyperplasia
may
involv
line
epithelium
alveoli
bronchioli
form
hyperplasia
term
alveolar
hyperplasia
adenomatosi
alveolar
bronchiolis
epithelialis
rat
form
hyperplasia
occur
spontan
induc
infect
administr
xenobiot
rat
coleman
et
al
goodman
et
al
kroe
et
al
greav
faccini
mice
ward
et
al
hamster
rehm
et
al
whether
alveolar
hyperplasia
result
hyperplasia
type
ii
cell
bronchiolar
cell
migrat
alveoli
disput
rehm
et
al
histolog
lesion
consist
localis
unencapsul
foci
hyperchromat
regular
cuboid
columnar
cell
invest
airspac
without
appreci
distort
alveolar
wall
anoth
form
hyperplasia
well
describ
hamster
neuroendocrin
hyperplasia
although
small
aggreg
neuroendocrin
cell
neuroepitheli
bodi
found
variou
level
bronchi
bronchioli
normal
hamster
administr
nitrosamin
produc
neuroendocrin
hyperplasia
linnoila
et
al
ito
et
al
hyperplast
lesion
recognis
group
noncili
cuboid
oval
columnar
cell
locat
bronchial
bronchiolar
epithelium
contain
argyrophil
granul
show
immunoreact
corticotrophin
acth
neuronespecif
enolas
ito
et
al
linnoila
et
al
ultrastructur
examin
reveal
presenc
densecor
cytoplasm
granul
apud
type
linnoila
et
al
ito
et
al
common
lung
neoplasm
man
bronchogen
squamou
carcinoma
occasion
observ
spontan
pulmonari
neoplasm
laboratori
rodent
includ
rat
goodman
et
al
good
experiment
model
small
cell
oat
cell
cancer
compris
lung
cancer
man
believ
neuroendocrin
deriv
becker
gazder
far
common
primari
pulmonari
neoplasm
found
laboratori
rat
mice
hamster
adenoma
adenocarcinoma
appear
develop
bronchiolar
alveolar
epithelium
although
precis
histogenesi
somewhat
disput
although
spontan
squamou
neoplasm
uncommon
rodent
subject
debat
cystic
keratinis
lesion
induc
rat
high
burden
particul
materi
lung
boorman
et
al
pleural
mesothelioma
mesenchym
neoplasm
also
occur
speci
rare
mesenchym
tumour
similar
histolog
featur
soft
tissu
mesothelioma
may
show
either
epitheli
mesenchym
differenti
rat
strain
alveolar
bronchiolar
neoplasm
occur
spontan
rel
small
number
morpholog
ident
neoplasia
induc
administr
chemic
carcinogen
reznik
common
classifi
bronchioloalveolar
adenoma
pulmonari
adenoma
bronchioloalveolar
carcinoma
nation
toxicolog
program
databas
control
fischer
rat
use
carcinogen
studi
indic
overal
percentag
less
anim
bronchioloalveolar
adenoma
less
bronchioloalveolar
carcinoma
haseman
et
al
howev
rang
bronchioloalveolar
adenoma
seri
histolog
bronchioloalveolar
tumour
mostli
small
discret
round
nodul
locat
lung
parenchyma
compos
fairli
uniform
cell
moder
hyperchromat
nuclei
arrang
solid
alveolar
tubular
papillari
mix
growth
pattern
usual
compress
surround
tissu
without
infiltr
metastat
spread
adenoma
although
loss
differenti
infiltr
spread
adjac
tissu
occur
adenocarcinoma
ultrastructur
studi
bronchiolaralveolar
neoplasia
fischer
rat
shown
presenc
osmiophil
lamel
inclus
bodi
similar
found
alveolar
type
ii
cell
therefor
suggest
neoplasm
deriv
cell
type
reznik
howev
lamellar
inclus
occur
cell
type
includ
clara
cell
rehm
et
al
pulmonari
squamou
carcinoma
occur
uncommon
spontan
neoplasm
rat
schwartz
et
al
larg
prolif
benign
cystic
lesion
found
lung
rat
follow
accumul
larg
amount
particul
matter
term
pulmonari
cystic
keratinis
epithelioma
regard
benign
neoplasm
lesion
show
evid
tissu
invas
regard
pulmonari
squamou
cell
carcinoma
boorman
et
al
similar
lesion
occasion
report
spontan
lesion
rittinghausen
kaspareit
analog
neoplasm
found
commonli
strain
laboratori
mice
use
carcinogen
bioassay
although
consider
report
variat
incid
common
strain
mice
observ
low
frequenc
month
age
incid
reach
nearli
month
age
stoner
shimkin
fewer
signific
number
found
mice
although
consider
interlaboratori
variat
presenc
neoplasm
report
taron
et
al
nation
fig
lung
mous
show
typic
round
wellcircumscrib
adenoma
magnif
uniform
tubular
papillari
structur
evid
toxicolog
program
data
base
control
mice
use
carcinogen
studi
indic
overal
percentag
male
femal
bronchioloalveolar
adenoma
respect
bronchioloalveolar
carcinoma
haseman
et
al
howev
rang
bronchioloalveolar
tumour
vari
consider
studi
seri
even
laboratori
mice
hous
similar
condit
show
variat
incid
neoplasm
time
incid
lung
adenoma
adenocarcinoma
occur
mice
use
control
carcinogen
bioassay
laboratori
similar
condit
period
year
vari
male
femal
faccini
et
al
contrast
strain
mice
strain
show
low
predisposit
lung
adenoma
tucker
contrast
bronchioloalveolar
neoplasm
squamou
carcinoma
report
seri
mous
studi
histolog
pulmonari
tumour
type
mice
gener
small
sharpli
circumscrib
nodul
compos
fairli
uniform
close
pack
column
cuboid
columnar
cell
arrang
tubular
papillari
structur
scanti
fibrovascular
stroma
fig
may
less
well
differenti
cellular
pleomorph
show
intrabronchi
growth
invad
lung
parenchyma
produc
metastat
spread
stewart
et
al
precis
histogenesi
mous
pulmonari
adenoma
adenocarcinoma
disput
basi
sequenti
light
electron
microscop
studi
pulmonari
adenoma
induc
baggwebst
swiss
mice
transplacent
exposur
ethylnitrosourea
suggest
develop
either
alveolar
type
ii
cell
clara
cell
kauffman
et
al
kauffman
care
stepwis
analysi
use
light
microscop
electron
microscop
examin
show
adenoma
fell
three
principl
group
compos
solid
growth
uniform
cuboid
cell
expand
margin
limit
alveolar
septa
alveolar
pattern
cell
contain
concentr
arrang
cytoplasm
lamellar
bodi
abund
larg
mitochondria
similar
mitochondria
found
alveolar
type
ii
cell
pattern
tubular
papillari
type
compos
cuboid
cell
show
histolog
ultrastructur
featur
clara
cell
differenti
base
time
sequenc
develop
suggest
tumour
tubular
arrang
evolv
papillari
adenoma
experiment
model
kauffman
immunocytochem
studi
chemicallyinduc
spontan
pulmonari
neoplasia
balbc
strain
mice
shown
major
adenocarcinoma
includ
show
papillari
pattern
contain
immunereact
surfact
apoprotein
typic
type
ii
antigen
suggest
neoplasm
alveolar
type
ii
deriv
ward
et
al
gun
et
al
examin
rang
adenoma
strain
mice
show
proport
tumour
papillari
solidalveolar
growth
pattern
vari
induc
agent
suggest
certain
biolog
differ
exist
two
histolog
subtyp
perhap
find
surpris
view
pluripotenti
natur
lung
precursor
cell
fact
differenti
may
proceed
along
differ
pathway
tumour
progress
potenti
modifi
xenobiot
usual
high
incid
inher
variabl
pulmonari
adenoma
adenocarcinoma
convent
mous
carcinogen
bioassay
sometim
give
rise
statist
signific
differ
control
treatment
group
frank
genotox
carcinogen
also
increas
preval
similar
neoplasm
strain
mice
consider
risk
overinterpret
group
differ
convent
mous
bioassay
analysi
group
differ
import
consider
given
tissu
sampl
procedur
agestandardis
histor
control
incid
effect
food
intak
result
mutagen
studi
carcinogen
bioassay
rodent
speci
instanc
carcinogen
bioassay
mice
treat
week
synthet
analges
tilidin
fumar
statist
signific
differ
p
report
incid
lung
adenocarcinoma
top
dose
femal
group
concurr
control
mcguir
et
al
argu
group
differ
indic
tumorigen
potenti
tilidin
fumar
basi
incid
high
dose
group
within
histor
control
rang
tumorigen
effect
evid
analog
rat
carcinogen
studi
difficult
evalu
concern
metronidazol
nitroimidazol
import
therapeut
agent
activ
anaerob
organ
trichomona
speci
administr
compound
led
increas
incid
pulmonari
adenoma
carcinoma
three
separ
mous
carcinogen
bioassay
rustia
shubik
roe
analysi
find
complic
evid
metronidazol
show
mutagen
activ
bacteri
assay
use
strain
salmonella
typhimurium
roe
argu
risk
man
slight
increas
preval
pulmonari
tumour
like
result
chang
nutrit
statu
mice
effect
metronidazol
gut
flora
similar
differ
could
occur
ad
libitum
fed
mice
fed
restrict
diet
also
suggest
posit
find
bacteri
mutagenesi
assay
inher
part
antibacteri
activ
metronidazol
result
nitroreduct
occur
normal
mammalian
tissu
conclus
support
neg
effect
hamster
carcinogen
bioassay
supplement
genotox
test
well
lack
excess
cancer
risk
women
follow
year
roe
common
occurr
lung
adenoma
strain
mice
utilis
develop
quantit
bioassay
carcinogen
activ
follow
demonstr
administr
carcinogen
strain
could
significantli
increas
incid
pulmonari
adenoma
within
period
month
shimkin
mani
year
strain
mous
pulmonari
tumour
assay
use
test
larg
number
chemic
differ
class
includ
polycycl
hydrocarbon
nitrosamin
food
addit
alkyl
halid
metal
chemotherapeut
agent
stoner
et
al
gun
et
al
howev
mani
biolog
system
interlaboratori
agreement
strain
test
system
correl
carcinogen
studi
data
genotox
result
shown
poor
particular
care
need
interpret
test
maronpot
et
al
nevertheless
may
serv
help
rank
tumorigen
activ
anticanc
drug
provid
cognis
given
drug
stabil
rout
administr
vehicl
well
speci
differ
metabol
drug
disposit
hamster
develop
lung
adenoma
spontan
small
number
advanc
age
compos
uniform
cylindr
cell
similar
found
bronchial
epithelium
goblet
cell
show
distinct
mucu
product
pour
et
al
pour
et
al
mohr
ketkar
immunohistochem
studi
similar
pulmonari
neoplasm
induc
hamster
nnitrosodiethylamin
shown
presenc
clara
cell
antigen
earli
phase
develop
tumour
develop
becam
squamou
type
show
immunoreact
cytokeratin
rehm
et
al
predominantli
clara
cell
origin
suggest
neoplasm
